Alinwell vs MyDrHank

Strengths

• +Runs four GLP-1 lanes rather than two: injectable semaglutide, injectable tirzepatide, an oral GLP-1 and a microdose program
• +Care coaching and a dietitian visit are included in the plan panel at no separate charge, and a same-day clinician call is offered without a fee
• +Publishes certificates of analysis for its semaglutide and tirzepatide batches, and four compounding pharmacies are named on those certificates
• +Sells a large priced peptide catalog beside the GLP-1 lines, so a reader can see what the rest of the menu costs

Where it loses points

• –The advertised figure is a first-month price. Checkout labels $149 and $199 as “$100 off first month” and strikes $249 and $299 beside them
• –The three-month plan costs more per month than the advertised monthly price, because the advertised price is an introductory one
• –Three incompatible cancellation rules are live at once: 48 hours’ notice in the Terms, 30 days’ notice in the treatment FAQ, and “cancel anytime” on the checkout
• –The Terms and Privacy pages give the mailing address as “123 Example Street, Suite 100, Your City, WI, 92308” — an unedited template, and 92308 is a California ZIP
• –No clinician, medical director or medical group is named anywhere on the site
• –The pharmacy names appear only on batch certificates, and the site never states which one fills a given order or under what compounding class

Strengths

• +Prices are published openly on the product pages, before any intake quiz — most compounded competitors gate the number behind a questionnaire
• +A real oral semaglutide tablet ($249/mo month-to-month) beside the weekly injection, so the needle is optional on the semaglutide line
• +The GLP-1 pages state the price stays the same at every dose, so titrating up does not raise the monthly cost
• +Six prescription lines on one account — weight loss, longevity, peptides and NAD+, sexual health, hair growth and strength — with free shipping included
• +Clean against the FDA warning-letter database: no letter on file under the brand, the entity or the domain

Where it loses points

• –Every price MyDrHank displays is the twelve-month prepay rung — its price component renders the cheapest term in the ladder, so the month-to-month rate ($259 semaglutide, $349 tirzepatide) appears on no page on the site
• –Month-to-month, it is expensive: $259 semaglutide against a $179 median across the providers here that disclose one, and $349 tirzepatide against a $249 median
• –One advertised price is purchasable at no tier — a footnote quotes "$200/mo for compounded tirzepatide" when the cheapest tirzepatide rung is $240, and the "$171/mo" beside it is the oral product's yearly rate, not injectable semaglutide's ($178)
• –An FAQ describes a twelve-month prepay rate as a plan with "no contract"
• –Compounded only and not FDA-approved — no brand Wegovy, Ozempic, Zepbound or Mounjaro lane at any price
• –The operating entity is named — Dr. Hank, LLC, credited in the privacy policy and terms of use — but nobody clinical is: no medical director or prescriber appears anywhere, no lab or monitoring program is published, and the compounding pharmacy is described only as "an FDA-registered U.S. pharmacy"
• –The trust row reads "HIPAA-aware", not HIPAA-compliant — a hedge worth noticing on a site handling prescription intake
• –No served-states list appears on the consumer site; the affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia